|
Name |
Terpendole I
|
Molecular Formula | C27H35NO5 | |
IUPAC Name* |
(1S,2R,5S,7S,8R,9R,11S,12S,15S)-7-(2-hydroxypropan-2-yl)-1,2-dimethyl-6,10-dioxa-24-azaheptacyclo[13.10.0.02,12.05,11.09,11.017,25.018,23]pentacosa-17(25),18,20,22-tetraene-8,12-diol
|
|
SMILES |
C[C@]12CC[C@H]3[C@@]4([C@@]1(CC[C@@H]5[C@@]2(C6=C(C5)C7=CC=CC=C7N6)C)O)[C@H](O4)[C@@H]([C@H](O3)C(C)(C)O)O
|
|
InChI |
InChI=1S/C27H35NO5/c1-23(2,30)21-19(29)22-27(33-22)18(32-21)10-11-24(3)25(4)14(9-12-26(24,27)31)13-16-15-7-5-6-8-17(15)28-20(16)25/h5-8,14,18-19,21-22,28-31H,9-13H2,1-4H3/t14-,18-,19+,21-,22+,24+,25+,26-,27-/m0/s1
|
|
InChIKey |
AKOANWZRKXOJTC-ZWNZASDISA-N
|
|
Synonyms |
Terpendole I; 167612-17-1; (1S,2R,5S,7S,8R,9R,11S,12S,15S)-7-(2-hydroxypropan-2-yl)-1,2-dimethyl-6,10-dioxa-24-azaheptacyclo[13.10.0.02,12.05,11.09,11.017,25.018,23]pentacosa-17(25),18,20,22-tetraene-8,12-diol; (2S,3R,3aR,4aS,4bS,6aS,12bS,12cR,14aS)-3,3a,5,6,6a,7,12,12b,12c,13,14,14a-dodecahydro-2-(1-hydroxy-1-methylethyl)-12b,12c-dimethyl-2H,4bH-oxireno[4',4'a]-1-benzopyrano[5',6':6,7]indeno[1,2-b]indole-3,4b-diol; SCHEMBL20869892; CHEBI:144412; HY-N8331; CS-0143226; C20543
|
|
CAS | NA | |
PubChem CID | 10026941 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 453.6 | ALogp: | 3.0 |
HBD: | 4 | HBA: | 5 |
Rotatable Bonds: | 1 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 98.2 | Aromatic Rings: | 7 |
Heavy Atoms: | 33 | QED Weighted: | 0.493 |
Caco-2 Permeability: | -5.142 | MDCK Permeability: | 0.00001560 |
Pgp-inhibitor: | 0.275 | Pgp-substrate: | 0.985 |
Human Intestinal Absorption (HIA): | 0.017 | 20% Bioavailability (F20%): | 0.016 |
30% Bioavailability (F30%): | 0.286 |
Blood-Brain-Barrier Penetration (BBB): | 0.773 | Plasma Protein Binding (PPB): | 76.80% |
Volume Distribution (VD): | 1.036 | Fu: | 17.90% |
CYP1A2-inhibitor: | 0.143 | CYP1A2-substrate: | 0.927 |
CYP2C19-inhibitor: | 0.054 | CYP2C19-substrate: | 0.754 |
CYP2C9-inhibitor: | 0.09 | CYP2C9-substrate: | 0.062 |
CYP2D6-inhibitor: | 0.023 | CYP2D6-substrate: | 0.384 |
CYP3A4-inhibitor: | 0.438 | CYP3A4-substrate: | 0.49 |
Clearance (CL): | 9.464 | Half-life (T1/2): | 0.298 |
hERG Blockers: | 0.719 | Human Hepatotoxicity (H-HT): | 0.797 |
Drug-inuced Liver Injury (DILI): | 0.053 | AMES Toxicity: | 0.019 |
Rat Oral Acute Toxicity: | 0.971 | Maximum Recommended Daily Dose: | 0.946 |
Skin Sensitization: | 0.343 | Carcinogencity: | 0.939 |
Eye Corrosion: | 0.005 | Eye Irritation: | 0.016 |
Respiratory Toxicity: | 0.989 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC003929 | 0.703 | D0H4JM | 0.295 | ||||
ENC003930 | 0.692 | D0U7GP | 0.256 | ||||
ENC003931 | 0.692 | D01JGV | 0.256 | ||||
ENC003834 | 0.685 | D04RLY | 0.242 | ||||
ENC002013 | 0.631 | D06AWE | 0.240 | ||||
ENC003787 | 0.621 | D0H2JP | 0.240 | ||||
ENC000836 | 0.588 | D0OT9S | 0.231 | ||||
ENC004710 | 0.574 | D01KQA | 0.230 | ||||
ENC005989 | 0.570 | D02STN | 0.228 | ||||
ENC003172 | 0.570 | D0Z1FX | 0.228 |